Fundraising FoxADEPTRIX CORP
1 known investors
Find your way into ADEPTRIX CORP
Sign up to see every warm intro you have to ADEPTRIX CORP
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ADEPTRIX CORP team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Adeptrix develops the exoBAMS platform, using antibody-based immunoaffinity capture of extracellular vesicles combined with MALDI mass spectrometry to profile proteins, lipids, metabolites and other molecules from a single blood sample. It provides custom assay development and bioanalytical services to researchers for biomarker discovery, disease-signature analysis, and translational research in oncology, neurology, and other disease areas.
Founders & leadership
Investors · 1
Non-dilutive funding · 6 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $2.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $1.3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $1.5M |
| National Science Foundation | Phase II | 2015 | $750K |
| National Science Foundation | Phase I | 2013 | $150K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2012 | $698.1K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does ADEPTRIX CORP do?
- Adeptrix develops the exoBAMS platform, using antibody-based immunoaffinity capture of extracellular vesicles combined with MALDI mass spectrometry to profile proteins, lipids, metabolites and other molecules from a single blood sample. It provides custom assay development and bioanalytical services to researchers for biomarker discovery, disease-signature analysis, and translational research in oncology, neurology, and other disease areas.
- Who founded ADEPTRIX CORP?
- ADEPTRIX CORP was founded by Vladislav Bergo.
- Who are ADEPTRIX CORP's investors?
- ADEPTRIX CORP's investors include Formation Venture Engineering.